What Maypo does

Maypo is a Mexico City-headquartered pharmaceutical distribution and fourth-party logistics (4PL) company specializing in high-specialty medicines and cold chain products. Founded in 1993 by the Arenas family and operating for 30+ years, the company serves Mexican government health institutions — including ISSSTE (850+ hospitals, 150M+ units annually), PEMEX, SSA, IMSS, and INCAN — as well as 30+ transnational pharmaceutical companies via its Vanguardia business model. Core operations are anchored by Campus Maypo, a 90,000 m³ automated logistics center (described as the most modern in Latin America), featuring Multishuttle equipment, Voice Picking systems, SAP ERP, and computerized temperature/humidity monitoring, supporting 12-24 hour nationwide cold-chain delivery.

The company generates revenue through managed distribution, storage, and dispensing services (Logistics, Distribution, Importación, Asuntos Regulatorios), supplemented by higher-value specialized services including pharmaceutical compounding (Central de Mezclas), business intelligence (Maypo Insights 2.0 platform), and strategic partner services (SEA). Pricing is via custom B2B contracts with healthcare institutions and pharmaceutical laboratories — no public pricing is disclosed. Maypo holds COFEPRIS sanitary licenses for controlled drugs (Classes I, II, III) and biologicals, ISO 9001:2015 cold chain certification, and GMP compliance. Go-to-market is sales-led enterprise field sales with dedicated account managers for hospital/institution clients and laboratory/commercial partners. The company remains family-owned (Arenas family) with no external institutional investment or public listing, operating exclusively in Mexico with no disclosed international expansion.

Name

Maypo

Legal name

Farmacéuticos Maypo, S.A. de C.V.

Website

https://maypo.com

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Maypo is a Mexico-based pharmaceutical 4PL distributor specializing in cold chain and high-specialty medicines, serving Mexican government health institutions (ISSSTE, PEMEX, SSA, IMSS) and 30+ transnational pharma companies through its automated Campus Maypo logistics center.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution & Cold Chain Logistics

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL)

akta.pro secondary industries

4PL / Lead Logistics Provider (LLP) & Control Tower (TLAIABAA), Industry-Specific Contract Logistics (Automotive, Pharma, Retail, Aerospace, etc.) (TLAIAAAL), Exception Management, Track & Trace & Visibility Operations (SLA/KPI Governance) (TLAIABAF)

Keywords

• Pharmaceutical distribution
• Cold chain logistics
• High specialty medicines
• Pharmaceutical 4PL services
• Healthcare supply chain

Headquarters

HQ city

Coyoacán

HQ country

Mexico

HQ region

Latin America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution Services: Core distribution, storage, dispensing, and commercialization services for medications of high specialty and cold chain products, serving pharmaceutical industry and healthcare sector
2. Logistics Services (4PL): Fourth-party logistics provider specializing in cold chain, high specialty products, clinical protocols and operational processes for pharmaceutical industry
3. Distribution Services: Air and ground distribution services for medications with cold chain requirements, ensuring 12-24 hour delivery nationwide
4. Import Services: Import support for pharmaceutical products including acquisition follow-up, manufacturer contact, and regulatory compliance for laboratories
5. Regulatory Affairs: Compliance and quality management services for logistics processes including ISO certifications and COFEPRIS licensing
6. Business Intelligence: Strategic additional services (SEA) providing added value to business partners through data and insights

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Maypo is a Mexican pharmaceutical fourth-party logistics (4PL) provider that distributes, stores, and commercializes high-specialty and cold chain medicines on behalf of pharmaceutical laboratories and healthcare institutions. Its offering spans 4PL logistics, air and ground cold chain distribution with 12-24 hour nationwide delivery, import support for foreign manufacturers, regulatory affairs under COFEPRIS and ISO 9001:2015 frameworks, pharmaceutical compounding (Central de Mezclas), business intelligence, and the Vanguard model serving 30+ transnational pharmaceutical companies.

Product overview

Maypo is a pharmaceutical distribution company offering an integrated suite of logistics and supply chain services for the healthcare industry. The core offering consists of 4PL logistics services specializing in cold chain management and high-specialty medicines, complemented by air and ground distribution with 12-24 hour delivery times, import services for pharmaceutical products, and regulatory affairs support. The portfolio includes specialized services such as the Vanguard innovative business model, Central de Mezclas for pharmaceutical compounding, and the Maypo Insights digital platform for real-time order tracking. The company operates as a 4PL (Fourth-Party Logistics) provider with advanced automation infrastructure including Multishuttle systems and SAP ERP.

Differentiator

Problem solved

Functional benefit

Brands

• Vanguardia: Business model created in 2019 serving transnational pharmaceutical companies with innovative logistics services.
• SEA (Servicios Estratégicos Adicionales)
• Maypo Insights

Products and services

• Logística (4PL Logistics) 4PL logistics service specializing in Cold Chain Network, high specialty products, clinical protocols, and operational processes aligned with the pharmaceutical industry, complying with GMP standards and sanitary storage requirements.
• Distribución (Distribution) Transport of medicines in cold chain with specialized protocols and transport units; air and ground distribution with delivery times of 12 to 24 hours throughout Mexico.
• Importación (Imports) Assists pharmaceutical laboratories with importing pharmaceutical products, including acquisition follow-up, contacting foreign manufacturers, and advising on requirements from governmental entities, customs authorities, and sanitary control agencies.
• Asuntos Regulatorios (Regulatory Affairs) Quality management systems aligned with ISO 9001:2015 for logistics processes, including compliance with COFEPRIS operating licenses and good storage and distribution practices.
• Vanguard (Vanguardia) Innovative business model launched in 2019, recognized by the transnational pharmaceutical industry as innovative, providing service to over 30 pharmaceutical companies with tailored distribution and commercialization offerings.
• Central de Mezclas (Mixing Center) Pharmaceutical compounding service for customized medication preparation.
• Inteligencia de Negocios (Business Intelligence) Business intelligence services providing data analysis and insights for operational decision-making.
• Unidad de Servicios Logísticos (USL) Logistical services unit created in 2009 to provide specialized logistics support.
• Maypo Insights (platform v2.0) Real-time tracking platform launched in 2023 that allows viewing of order process from receipt to delivery/collection, with version 2.0 introducing enhanced visibility and stakeholder access.

Quantifiable outcome

• 850+ hospitals served with 150+ million units annually for ISSSTE
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators9 records

Recent moves9 records

Expansion highlights4 records

Broad incumbents

• CEVA Logistics (Healthcare): Global contract logistics provider with a Healthcare vertical offering pharma cold chain warehousing and distribution. Comparable service portfolio to Maypo's 4PL offering and increasingly active in Latin America.
• McKesson Corporation: Global pharmaceutical distributor and wholesaler with operations across North America. Represents the multinational incumbent that Maypo's Vanguardia unit competes against for transnational pharma contracts in Mexico.
• Cencora (formerly AmerisourceBergen): One of the largest global pharmaceutical distribution and consulting services companies. Direct competitor for high-value specialty pharma distribution contracts in Latin America and a benchmark for what scale logistics looks like.
• DHL Supply Chain (Life Sciences): Global contract logistics provider with a dedicated Life Sciences & Healthcare division offering cold chain pharma warehousing and distribution. Comparable to Maypo's 4PL cold chain offering but at vastly greater geographic and capital scale.
• Kuehne+Nagel (KN PharmaChain): Global logistics provider with a dedicated pharma & healthcare vertical (KN PharmaChain) covering cold chain airfreight, warehousing, and distribution. Competes for the same multinational pharma clients that Maypo's Vanguardia targets.

Emerging players

• UPS Healthcare: Global logistics and supply chain operator with a growing healthcare vertical focused on cold chain pharma distribution, cold storage, and clinical trial logistics. Overlaps with Maypo's cold chain 4PL focus and represents the kind of well-capitalized entrant Maypo must defend against.

Direct peers

• Dimesa (Distribuidora Internacional de Medicamentos): Major Mexican pharmaceutical distributor serving government institutions (IMSS, ISSSTE) and private pharmacies with national coverage. Closely mirrors Maypo's mix of public-sector contract logistics and pharmaceutical wholesale.
• Grupo Casa Saba: One of the largest Mexican pharmaceutical distributors, providing wholesale distribution and specialized logistics services to pharmacies, hospitals, and government health institutions — directly comparable to Maypo in customer base (Mexican health sector) and business model (pharma wholesale/3PL).
• Droguería Internacional (DI): Mexican pharmaceutical wholesaler distributing drugs and druggists' sundries to pharmacies and institutions. Directly comparable on wholesale pharma distribution and customer base.
• Grupo Bruluart: Mexican pharmaceutical distributor with national reach, serving retail pharmacies and healthcare institutions. Comparable to Maypo in product category, customer overlap, and distribution-driven B2B model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights2 records

Customer concentration

• LinkedInlinkedin.com/company/farmace-ticos-maypo

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maypo